pioglitazone has been researched along with Escherichia coli Infections in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Escherichia coli Infections: Infections with bacteria of the species ESCHERICHIA COLI.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Miyazaki, H | 1 |
Kinoshita, M | 2 |
Nakashima, H | 2 |
Nakamura, S | 1 |
Saitoh, D | 1 |
Nakashima, M | 1 |
Kotani, A | 1 |
Ishikiriyama, T | 1 |
Kato, S | 1 |
Hiroi, S | 1 |
Seki, S | 1 |
2 other studies available for pioglitazone and Escherichia coli Infections
Article | Year |
---|---|
Pioglitazone Modifies Kupffer Cell Function and Protects against
Topics: Animals; Bacteremia; Escherichia coli; Escherichia coli Infections; Hypoglycemic Agents; Kupffer Cel | 2022 |
Pioglitazone improves phagocytic activity of liver recruited macrophages in elderly mice possibly by promoting glucose catabolism.
Topics: Aging; Animals; CD11b Antigen; Cytokines; Escherichia coli; Escherichia coli Infections; Glucose; In | 2019 |